ClinConnect ClinConnect Logo
Search / Trial NCT06897514

External Validation of Prediction Algorithm Using Non-invasive Monitoring Device for Intraoperative Hypotension

Launched by SAMSUNG MEDICAL CENTER · Mar 25, 2025

Trial Information

Current as of April 26, 2025

Not yet recruiting

Keywords

Intraoperative Hypotension Prediction Algorithm

ClinConnect Summary

This clinical trial is studying a new way to predict low blood pressure during surgery by using a special monitoring device that does not require any needles or invasive procedures. The researchers want to find out if this prediction method can accurately identify when a patient might experience low blood pressure while they are under general anesthesia. This is important because low blood pressure during surgery can lead to complications.

To participate in this study, you need to be an adult, 19 years or older, and scheduled for an elective surgery that will be done with general anesthesia. You should be in good health or have mild to moderate health issues as described by the American Society of Anesthesiologists. However, if you need certain medications before surgery, require invasive monitoring, are having an emergency procedure, or are pregnant or breastfeeding, you won’t be eligible to join. If you take part in the trial, you will help researchers learn more about how to keep patients safe during surgery by improving monitoring techniques.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults patients aged 19 or more
  • Elective surgery under general anesthesia
  • American Society of Anesthesiologists physical status I - III
  • Exclusion Criteria:
  • Vasopressor/Inotrope usage before surgery
  • Patients who needs invasive arterial cannulation
  • Emergency surgery
  • Pregnant or lactating women

About Samsung Medical Center

Samsung Medical Center (SMC) is a leading healthcare institution in South Korea, renowned for its commitment to advancing medical research and innovation. As a prominent clinical trial sponsor, SMC integrates cutting-edge technology and expert clinical practices to conduct rigorous studies aimed at improving patient outcomes. The center is dedicated to fostering collaborations with global research entities and adhering to the highest ethical standards, ensuring the integrity and reliability of its clinical trials. With a focus on diverse therapeutic areas, SMC plays a pivotal role in translating scientific discoveries into effective treatments, ultimately enhancing the quality of healthcare worldwide.

Locations

Patients applied

0 patients applied

Trial Officials

Hyun Joo Ahn, MD PhD

Principal Investigator

Samsung Medical Center, Sungkyunkwan University School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported